Herbas VPB

Print
EN | LT
LT - 2,3-Dipakeistieji 1-acil-4-amino-1,2,3,4-tetrahidrochinolino dariniai ir jų panaudojimas kaip bromodomeno inhibitorių
EN - 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 215/227 (2006.01)
C07D 215/44 (2006.01)
C07D 215/46 (2006.01)
C07D 215/48 (2006.01)
A61K 31/4706 (2006.01)
A61K 31/4709 (2006.01)
A61K 31/4375 (2006.01)
C07D 401/04 (2006.01)
C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
C07D 405/04 (2006.01)
C07D 405/14 (2006.01)
C07D 409/12 (2006.01)
C07D 409/14 (2006.01)
C07D 413/04 (2006.01)
European patent
(11) Number of the document 2970127
(13) Kind of document T
(96) European patent application number 14713394.6
Date of filing the European patent application 2014-03-12
(97) Date of publication of the European application 2016-01-20
(45) Date of publication and mention of the grant of the patent 2018-10-24
(46) Date of publication of the claims translation 2019-02-11
PCT application
(86) Number PCT/EP2014/054795
Date 2014-03-12
PCT application publication
(87) Number WO 2014/140076
Date 2014-09-18
Priority applications
(30) Number Date Country code
201361781583 P 2013-03-14 US
201361882798 P 2013-09-26 US
Inventors
(72)
AMANS, Dominique, GB
ATKINSON, Stephen John, GB
HARRISON, Lee Andrew, GB
HIRST, David Jonathan, GB
LAW, Robert Peter, GB
LINDON, Matthew, GB
PRESTON, Alexander, GB
SEAL, Jonathan Thomas, GB
WELLAWAY, Christopher Roland, GB
Grantee
(73) GlaxoSmithKline Intellectual Property (No. 2) Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, GB
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) 2,3-Dipakeistieji 1-acil-4-amino-1,2,3,4-tetrahidrochinolino dariniai ir jų panaudojimas kaip bromodomeno inhibitorių
  2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2025-03-03 12 289.00 EUR
Next renewal fee
2026-03-12